Amwell reports Q1 EPS ($1.42), consensus (21c)

Reports Q1 revenue $64M, consensus $64.7M. "Q1 was a very busy quarter for our company, one that provided a strong start to the year," said Dr. Ido Schoenberg, Chairman and CEO of Amwell. "We made great progress with customer migrations and strategic clients went live on Converge, our unique, one-stop-shop, hybrid care enablement platform. These successes provide valuable, in-market validation of the power and scale of Converge. Converge streamlines the simple, cohesive, and efficient delivery of hybrid healthcare. We also had a successful quarter of initiatives aimed at accelerating our momentum in the market."